Sunesis Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SNSS Sunesis Pharmaceuticals Inc
BAC Bank of America Corp
TDBZX AB Multi-Manager Select 2010 Fund Class Z
TDBYX AB Multi-Manager Select 2010 Fund Advisor Class
TDBRX AB Multi-Manager Select 2010 Fund Class R
TDBKX AB Multi-Manager Select 2010 Fund Class K
TDBCX AB Multi-Manager Select 2010 Fund Class C
TDAPX AB Multi-Manager Select 2055 Fund Class A
TDAGX AB Multi-Manager Select 2025 Fund Class A
ASFQX 361 U.S. Small Cap Equity Fund Investor Class
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD). The Company's other kinase inhibitor pipeline include TAK-580, SNS-062 and SNS-229. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). The Company has completed the pre-clinical studies for SNS-062. SNS-229 and SNS-510 are two PDK1 inhibitors. PDK1 is a kinase and mediator of Phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Closing Price
$0.6792
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
2,023,087
0
  • Prev Close
    0.6792
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    2.0M
  • Last (time)
    3:59p ET 06/19/19
  • Last (size)
    363
  • 52-Wk Range
    0.20 - 2.60
    LowHigh
  • (08/07/18 - 12/21/18)
    239.60%
  • 134.3%
  • Market Cap
    49.3M
  • Shares Outstanding
    72.5M
  • -0.64
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 3.0
  • 56.45
  • (% of float 05/31/19)
    1.21

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.